EICHOR
● Completed
Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
Condition: T2DM (Type 2 Diabetes Mellitus) · Sponsor: Shenzhen HighTide Biopharmaceutical Ltd.
About this study
The goal of this clinical study is to evaluate the efficacy and safety of berberine ursodeoxycholate (HTD1801) compared to dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (53)
| Beijing Pinggu Hospital | Beijing, China | — |
| Peking University People's Hospital | Beijing, China | — |
| Binzhou Medical University Hospital | Binzhou, China | — |
| Jilin Province FAW General Hospital | Changchun, China | — |
| The Second Hospital of Jilin University | Changchun, China | — |
| The First People's Hospital of Changde City | Changde, China | — |
| The First Hospital of Changsha City | Changsha, China | — |
| The Fourth Hospital of Changsha | Changsha, China | — |
| The Second Xiangya Hospital of Central South University | Changsha, China | — |
| The Third Xiangya Hospital of Central South University | Changsha, China | — |
| Bishan Hospital of Chongqing | Chongqing, China | — |
| People's Hospital of Deyang City | Deyang, China | — |
+ 41 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06415773